S100A6 and neoplasm: This anti-tumor effect was related to the downregulation of ERα, PRα&β, and TRPV1 expression, maintenance of immune function, especially by preserving NK cell activity, and reduced production of proinflammatory cytokines such as TNF-α and IL-6.